back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-13 11:48 Tx date 2026-03-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,924
-5,000 vol $3.98 each |
42,758 | |
| Filed 2026-03-02 11:04 Tx date 2026-02-26 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,514
-5,000 vol $4.10 each |
57,758 | |
| Filed 2026-03-02 11:03 Tx date 2026-02-26 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,639
-5,000 vol $4.13 each |
62,758 | |
| Filed 2026-03-02 11:00 Tx date 2026-03-02 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,517
-10,000 vol $3.85 each |
47,758 | |
| Filed 2026-02-23 12:36 Tx date 2026-02-20 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,914
-9,980 vol $4.30 each |
67,758 | |
| Filed 2026-02-23 12:35 Tx date 2026-02-19 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86.00
-20 vol $4.30 each |
77,738 | |
| Filed 2026-02-23 12:34 Tx date 2026-02-19 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,773
-10,000 vol $4.18 each |
77,758 | |
| Filed 2026-02-23 12:33 Tx date 2026-02-18 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,312
-10,000 vol $4.13 each |
87,758 | |
| Filed 2026-02-16 13:05 Tx date 2026-02-12 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,958
-10,000 vol $4.00 each |
97,758 | |
| Filed 2026-02-09 16:42 Tx date 2026-02-09 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$574,222
+103,092 vol $5.57 each |
1,107,891 | |
| Filed 2026-02-09 16:41 Tx date 2026-02-09 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$3,110,882
+614,799 vol $5.06 each |
1,004,799 | |
| Filed 2026-02-06 12:00 Tx date 2026-01-04 |
$NGEN
NervGen Pharma Corp. |
Kaye, Randall
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$111,500
+50,000 vol $2.23 each |
160,000 | |
| Filed 2026-02-06 11:59 Tx date 2026-01-04 |
$NGEN
NervGen Pharma Corp. |
Kaye, Randall
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-111,500
-50,000 vol $2.23 each |
535,000 | |
| Filed 2026-01-08 16:58 Tx date 2025-11-19 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Paul Fireman 2006 Revocable Trust (Indirect Ownership)
|
Warrants
99 - Correction of information
|
-428,571 vol |
0 | |
| Filed 2026-01-08 16:52 Tx date 2025-11-19 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Paul Fireman 2006 Revocable Trust (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
-857,143 vol |
0 | |
| Filed 2026-01-08 16:48 Tx date 2025-11-19 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Paul and Phyllis Fireman Charitable Foundation (PFP Foundation) (Control or Direction)
|
Warrants
99 - Correction of information
|
-476,190 vol |
0 | |
| Filed 2026-01-08 16:42 Tx date 2022-07-13 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Paul and Phyllis Fireman Charitable Foundation (PFP Foundation) (Control or Direction)
|
Warrants
99 - Correction of information
|
-1,439,574 vol |
0 | |
| Filed 2026-01-08 16:38 Tx date 2025-11-19 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Paul and Phyllis Fireman Charitable Foundation (PFP Foundation) (Control or Direction)
|
Common Shares
99 - Correction of information
|
-952,381 vol |
0 | |
| Filed 2026-01-08 16:36 Tx date 2022-07-13 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Paul and Phyllis Fireman Charitable Foundation (PFP Foundation) (Control or Direction)
|
Common Shares
99 - Correction of information
|
-2,879,149 vol |
0 | |
| Filed 2025-12-09 17:25 Tx date 2025-12-09 |
$NGEN
NervGen Pharma Corp. |
Kaye, Randall
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$176,000
+100,000 vol $1.76 each |
110,000 |